Studies show that immunotherapies may alter the treatment of kidney cancer
[ad_1] "It's a proof of principle that we can do it if the drugs are in the same class and tolerated when they are combined," said Dr. Toni Choueiri, director of the Lank Genitourinary Cancer Center. at the Dana-Farber Cancer Institute / Brigham and Women's Professor of Medicine at Harvard Medical School in Boston, lead … Read more